287 related articles for article (PubMed ID: 18403736)
1. DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke.
Diener HC; Schneider D; Lampl Y; Bornstein NM; Kozak A; Rosenberg G
Stroke; 2008 Jun; 39(6):1774-8. PubMed ID: 18403736
[TBL] [Abstract][Full Text] [Related]
2. Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke.
Lees KR; Bornstein N; Diener HC; Gorelick PB; Rosenberg G; Shuaib A;
Stroke; 2013 Mar; 44(3):580-4. PubMed ID: 23391764
[TBL] [Abstract][Full Text] [Related]
3. The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal phase III study.
Rosenberg G; Bornstein N; Diener HC; Gorelick PB; Shuaib A; Lees K;
Int J Stroke; 2011 Aug; 6(4):362-7. PubMed ID: 21645269
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of DP-b99 in healthy volunteers: first administration to humans.
Rosenberg G; Angel I; Kozak A
Br J Clin Pharmacol; 2005 Jul; 60(1):7-16. PubMed ID: 15963088
[TBL] [Abstract][Full Text] [Related]
5. Infrared laser therapy for ischemic stroke: a new treatment strategy: results of the NeuroThera Effectiveness and Safety Trial-1 (NEST-1).
Lampl Y; Zivin JA; Fisher M; Lew R; Welin L; Dahlof B; Borenstein P; Andersson B; Perez J; Caparo C; Ilic S; Oron U
Stroke; 2007 Jun; 38(6):1843-9. PubMed ID: 17463313
[TBL] [Abstract][Full Text] [Related]
6. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials.
Diener HC; Lees KR; Lyden P; Grotta J; Davalos A; Davis SM; Shuaib A; Ashwood T; Wasiewski W; Alderfer V; Hårdemark HG; Rodichok L;
Stroke; 2008 Jun; 39(6):1751-8. PubMed ID: 18369171
[TBL] [Abstract][Full Text] [Related]
7. The effect of Ginkgo biloba on functional outcome of patients with acute ischemic stroke: a double-blind, placebo-controlled, randomized clinical trial.
Oskouei DS; Rikhtegar R; Hashemilar M; Sadeghi-Bazargani H; Sharifi-Bonab M; Sadeghi-Hokmabadi E; Zarrintan S; Sharifipour E
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e557-63. PubMed ID: 23871729
[TBL] [Abstract][Full Text] [Related]
8. Does mild deficit for patients with stroke justify the use of intravenous tissue plasminogen activator?
Hassan AE; Zacharatos H; Hassanzadeh B; El-Gengaihy A; AlKawi A; Shhadeh A; Kirmani JF
J Stroke Cerebrovasc Dis; 2010 Mar; 19(2):116-20. PubMed ID: 20189087
[TBL] [Abstract][Full Text] [Related]
9. The lipophilic zinc chelator DP-b99 prevents zinc induced neuronal death.
Barkalifa R; Hershfinkel M; Friedman JE; Kozak A; Sekler I
Eur J Pharmacol; 2009 Sep; 618(1-3):15-21. PubMed ID: 19622352
[TBL] [Abstract][Full Text] [Related]
10. NXY-059 for acute ischemic stroke.
Lees KR; Zivin JA; Ashwood T; Davalos A; Davis SM; Diener HC; Grotta J; Lyden P; Shuaib A; Hårdemark HG; Wasiewski WW;
N Engl J Med; 2006 Feb; 354(6):588-600. PubMed ID: 16467546
[TBL] [Abstract][Full Text] [Related]
11. Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trial.
Heiss WD; Brainin M; Bornstein NM; Tuomilehto J; Hong Z;
Stroke; 2012 Mar; 43(3):630-6. PubMed ID: 22282884
[TBL] [Abstract][Full Text] [Related]
12. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group.
Grotta J
Stroke; 1997 Dec; 28(12):2338-46. PubMed ID: 9412611
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: a randomized, double-blind, placebo-controlled, phase II multicenter trial.
Liu X; Xia J; Wang L; Song Y; Yang J; Yan Y; Ren H; Zhao G
Eur J Neurol; 2009 May; 16(5):569-75. PubMed ID: 19236467
[TBL] [Abstract][Full Text] [Related]
14. Aptiganel hydrochloride in acute ischemic stroke: a randomized controlled trial.
Albers GW; Goldstein LB; Hall D; Lesko LM;
JAMA; 2001 Dec; 286(21):2673-82. PubMed ID: 11730442
[TBL] [Abstract][Full Text] [Related]
15. Ischemic stunning of the brain: early recanalization without immediate clinical improvement in acute ischemic stroke.
Alexandrov AV; Hall CE; Labiche LA; Wojner AW; Grotta JC
Stroke; 2004 Feb; 35(2):449-52. PubMed ID: 14726543
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial.
Shyu WC; Lin SZ; Lee CC; Liu DD; Li H
CMAJ; 2006 Mar; 174(7):927-33. PubMed ID: 16517764
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke.
Gulati A; Agrawal N; Vibha D; Misra UK; Paul B; Jain D; Pandian J; Borgohain R
CNS Drugs; 2021 Jan; 35(1):85-104. PubMed ID: 33428177
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin in the treatment of acute ischemic stroke.
Ehrenreich H; Weissenborn K; Prange H; Schneider D; Weimar C; Wartenberg K; Schellinger PD; Bohn M; Becker H; Wegrzyn M; Jähnig P; Herrmann M; Knauth M; Bähr M; Heide W; Wagner A; Schwab S; Reichmann H; Schwendemann G; Dengler R; Kastrup A; Bartels C;
Stroke; 2009 Dec; 40(12):e647-56. PubMed ID: 19834012
[TBL] [Abstract][Full Text] [Related]
19. Dodecafluoropentane Emulsion in Acute Ischemic Stroke: A Phase Ib/II Randomized and Controlled Dose-Escalation Trial.
Culp WC; Onteddu SS; Brown A; Nalleballe K; Sharma R; Skinner RD; Witt T; Roberson PK; Marsh JD
J Vasc Interv Radiol; 2019 Aug; 30(8):1244-1250.e1. PubMed ID: 31349978
[TBL] [Abstract][Full Text] [Related]
20. Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial.
Schellinger PD; Alexandrov AV; Barreto AD; Demchuk AM; Tsivgoulis G; Kohrmann M; Alleman J; Howard V; Howard G; Alexandrov AW; Brandt G; Molina CA;
Int J Stroke; 2015 Oct; 10(7):1141-8. PubMed ID: 26120902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
